Ca. Hillery et al., Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytesto thrombospondin and laminin, BR J HAEM, 109(2), 2000, pp. 322-327
The adhesion of sickle erythrocytes to the vascular endothelium and subendo
thelial matrix probably contributes to the pathogenesis of vaso-occlusive d
isease. The chemotherapeutic agent hydroxyurea (HU) decreases the frequency
of vaso-occlusive crises in patients with sickle cell disease. However, th
e exact mechanism(s) of HU's effect on vaso-occlusive crises is not fully u
nderstood. The goal of this study was to determine the effect of HU therapy
on the adhesion of sickle erythrocytes to the subendothelial matrix protei
ns thrombospondin (TSP) and laminin under conditions of now in vitro. Eryth
rocytes from patients with severe sickle cell disease on HU therapy (n = 14
) had significantly less adhesion to TSP (687 +/- 92 erythrocytes/mm(2), me
an +/-SE) than untreated patients with severe disease (n = 18, 1176 +/- 117
erythrocytes/mm(2), P = 0.003). In addition, there was significantly less
adhesion of erythrocytes to immobilized laminin in patients treated with HU
(1695 +/- 293 erythrocytes/mm(2)) than in the untreated patients (2590 +/-
296 erythrocytes/mm(2), P = 0.02). Erythrocytes from an additional nine pa
tients with severe sickle cell disease were studied both before and after i
nitiation of HU therapy. Erythrocytes from these patients became less adhes
ive to both TSP (P = 0.001) and laminin (P = 0.01), a change that was susta
ined in most patients throughout the duration of the study (2 months to > 1
2 months). This study suggests that RU modulates the adhesive phenotype of
sickle erythrocytes, an effect that may be in addition to, or independent o
f. other known effects of HU, such as an increase in fetal haemoglobin leve
l.